• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用生物活性细胞外基质片段作为尿道填充剂治疗压力性尿失禁。

Use of bioactive extracellular matrix fragments as a urethral bulking agent to treat stress urinary incontinence.

作者信息

Wang Ying, Duan Meng, Rahman Mahbubur, Yang Ming, Zhao Weixin, Zhou Shukui, Gao Guo, Fu Qiang

机构信息

Department of Urology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai Eastern Institute of Urologic Reconstruction, Shanghai Jiao Tong University, Shanghai 200233, China.

Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.

出版信息

Acta Biomater. 2020 Nov;117:156-166. doi: 10.1016/j.actbio.2020.09.049. Epub 2020 Oct 6.

DOI:10.1016/j.actbio.2020.09.049
PMID:33035698
Abstract

Injection of urethral bulking agents is a low-risk, minimally invasive surgical procedure to treat stress urinary incontinence (SUI). In this study, we developed a promising injectable bulking agent comprising extracellular matrix fragments of adipose-derived stem cell sheets (ADSC ECM) and investigated its effectiveness in urethral bulking therapy. The structural integrity and proteins of ADSC sheet ECM were well retained in decellularized ADSC ECM fragments. To locate transplanted ADSC ECM fragments, they were labeled with ultrasmall super-paramagnetic iron oxide nanoparticles, which enabled in vivo monitoring after implantation in a SUI rat model for up to 4 weeks. When ADSC ECM fragments were injected into the rat urethra, they became fully integrated with the surrounding tissue within 1 week. Four weeks after transplantation, host cells had regenerated within the ADSC ECM fragment injection area. Moreover, new smooth muscle tissue had formed around the ADSC ECM fragments, as confirmed by positive staining of myosin. These results indicate that injection of ECM fragments may be a promising minimally invasive approach for treating SUI.

摘要

注射尿道填充剂是一种治疗压力性尿失禁(SUI)的低风险、微创外科手术。在本研究中,我们研发了一种有前景的可注射填充剂,其由脂肪来源干细胞片(ADSC)的细胞外基质片段(ADSC ECM)组成,并研究了其在尿道填充治疗中的有效性。ADSC片ECM的结构完整性和蛋白质在脱细胞的ADSC ECM片段中得到了很好的保留。为了定位移植的ADSC ECM片段,用超小超顺磁性氧化铁纳米颗粒对其进行标记,这使得在植入SUI大鼠模型后长达4周的时间内都能进行体内监测。当将ADSC ECM片段注射到大鼠尿道中时,它们在1周内与周围组织完全整合。移植后4周,宿主细胞在ADSC ECM片段注射区域内再生。此外,如肌球蛋白阳性染色所证实的,在ADSC ECM片段周围形成了新的平滑肌组织。这些结果表明,注射ECM片段可能是一种治疗SUI的有前景的微创方法。

相似文献

1
Use of bioactive extracellular matrix fragments as a urethral bulking agent to treat stress urinary incontinence.使用生物活性细胞外基质片段作为尿道填充剂治疗压力性尿失禁。
Acta Biomater. 2020 Nov;117:156-166. doi: 10.1016/j.actbio.2020.09.049. Epub 2020 Oct 6.
2
Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model.经尿道注射自体脂肪来源干细胞联合控释神经生长因子治疗大鼠压力性尿失禁。
Eur Urol. 2011 Jan;59(1):155-63. doi: 10.1016/j.eururo.2010.10.038. Epub 2010 Oct 26.
3
Treatment of stress urinary incontinence with adipose tissue-derived stem cells.脂肪组织源性干细胞治疗压力性尿失禁。
Cytotherapy. 2010;12(1):88-95. doi: 10.3109/14653240903350265.
4
Activation of VEGF and ERK1/2 and improvement of urethral function by adipose-derived stem cells in a rat stress urinary incontinence model.脂肪源性干细胞通过激活 VEGF 和 ERK1/2 改善应激性尿失禁大鼠的尿道功能。
Urology. 2012 Oct;80(4):953.e1-8. doi: 10.1016/j.urology.2012.05.030. Epub 2012 Aug 28.
5
Therapeutic Potential of Human Adipose-Derived Stem Cell Exosomes in Stress Urinary Incontinence - An in Vitro and in Vivo Study.人脂肪来源干细胞外泌体在压力性尿失禁中的治疗潜力——一项体外和体内研究
Cell Physiol Biochem. 2018;48(4):1710-1722. doi: 10.1159/000492298. Epub 2018 Aug 3.
6
Tissue engineered bulking agent with adipose-derived stem cells and silk fibroin microspheres for the treatment of intrinsic urethral sphincter deficiency.组织工程化填充剂联合脂肪来源干细胞和丝素微球治疗内源性尿道括约肌缺陷。
Biomaterials. 2014 Feb;35(5):1519-30. doi: 10.1016/j.biomaterials.2013.11.025. Epub 2013 Nov 22.
7
Dual growth factor-loaded in situ gel-forming bulking agent: passive and bioactive effects for the treatment of urinary incontinence.负载双生长因子的原位凝胶形成填充剂:用于治疗尿失禁的被动和生物活性作用
J Mater Sci Mater Med. 2015 Jan;26(1):5365. doi: 10.1007/s10856-014-5365-3. Epub 2015 Jan 13.
8
A Functional Comparison of Treatment of Intrinsic Sphincter Deficiency with Muscle-Derived and Adipose Tissue-Derived Stem Cells.肌源性和脂肪源性干细胞治疗内括约肌缺陷的功能比较。
IUBMB Life. 2018 Oct;70(10):976-984. doi: 10.1002/iub.1896. Epub 2018 Sep 13.
9
Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: report of two initial cases.经尿道前列腺切除术后压力性尿失禁患者自体脂肪源性干细胞尿道周围注射治疗:两例初步报告。
Int J Urol. 2010 Jan;17(1):75-82. doi: 10.1111/j.1442-2042.2009.02429.x. Epub 2009 Nov 30.
10
Transcriptomic Analysis of Human Mesenchymal Stem Cell Therapy in Incontinent Rat Injured Urethra.人骨髓间充质干细胞治疗尿道失禁大鼠的转录组学分析。
Tissue Eng Part A. 2020 Jul;26(13-14):792-810. doi: 10.1089/ten.tea.2020.0033. Epub 2020 Jul 2.

引用本文的文献

1
Animal models, treatment options, and biomaterials for female stress urinary incontinence.女性压力性尿失禁的动物模型、治疗方案及生物材料
Front Bioeng Biotechnol. 2024 Aug 29;12:1414323. doi: 10.3389/fbioe.2024.1414323. eCollection 2024.
2
Decellularized Extracellular Matrix Scaffolds for Soft Tissue Augmentation: From Host-Scaffold Interactions to Bottlenecks in Clinical Translation.用于软组织增强的脱细胞细胞外基质支架:从宿主-支架相互作用到临床转化的瓶颈
Biomater Res. 2024 Sep 6;28:0071. doi: 10.34133/bmr.0071. eCollection 2024.
3
Preparation and Use of Decellularized Extracellular Matrix for Tissue Engineering.
用于组织工程的脱细胞细胞外基质的制备与应用
J Funct Biomater. 2022 Nov 14;13(4):240. doi: 10.3390/jfb13040240.
4
Therapies Based on Adipose-Derived Stem Cells for Lower Urinary Tract Dysfunction: A Narrative Review.基于脂肪来源干细胞治疗下尿路功能障碍的叙述性综述
Pharmaceutics. 2022 Oct 19;14(10):2229. doi: 10.3390/pharmaceutics14102229.
5
Implantation of adipose-derived mesenchymal stem cell sheets promotes axonal regeneration and restores bladder function after spinal cord injury.脂肪间充质干细胞片的植入促进了脊髓损伤后的轴突再生和膀胱功能的恢复。
Stem Cell Res Ther. 2022 Oct 12;13(1):503. doi: 10.1186/s13287-022-03188-1.
6
Establishment and evaluation of ectopic and orthotopic prostate cancer models using cell sheet technology.利用细胞片层技术建立和评估异位和原位前列腺癌模型。
J Transl Med. 2022 Aug 29;20(1):381. doi: 10.1186/s12967-022-03575-5.
7
Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues.基于新兴生物活性因子递送的下泌尿生殖组织再生疗法
Pharmaceutics. 2022 Aug 17;14(8):1718. doi: 10.3390/pharmaceutics14081718.
8
Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering.再生医学与组织工程中的氧化铁纳米颗粒
Nanomaterials (Basel). 2021 Sep 8;11(9):2337. doi: 10.3390/nano11092337.
9
In-vitro cellular and in-vivo investigation of ascorbic acid and β-glycerophosphate loaded gelatin/sodium alginate injectable hydrogels for urinary incontinence treatment.用于治疗尿失禁的负载抗坏血酸和β-甘油磷酸酯的明胶/海藻酸钠可注射水凝胶的体外细胞和体内研究。
Prog Biomater. 2021 Jun;10(2):161-171. doi: 10.1007/s40204-021-00160-9. Epub 2021 Jun 24.